Annual ROE
-47.24%
-6.48%-15.90%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual return on equity is -47.24%, with the most recent change of -6.48% (-15.90%) on June 30, 2024.
- During the last 3 years, AYTU annual ROE has risen by +2.88% (+5.75%).
- AYTU annual ROE is now -112.29% below its all-time high of 384.27%, reached on August 31, 2011.
Performance
AYTU ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-20.38%
+28.26%+58.10%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly return on equity is -20.38%, with the most recent change of +28.26% (+58.10%) on September 30, 2024.
- Over the past year, AYTU quarterly ROE has increased by +37.29% (+64.66%).
- AYTU quarterly ROE is now -102.83% below its all-time high of 719.27%, reached on August 31, 2009.
Performance
AYTU Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AYTU ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.9% | +64.7% |
| 3 y3 years | +5.8% | +70.3% |
| 5 y5 years | +82.1% | +49.3% |
AYTU ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.9% | +60.5% | at high | +83.5% |
| 5 y | 5-year | -77.1% | +82.1% | at high | +89.5% |
| alltime | all time | -112.3% | +95.0% | -102.8% | +99.4% |
Aytu BioPharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -20.38%(-58.1%) |
| Jun 2024 | -47.24%(+15.9%) | -48.64%(+25.2%) |
| Mar 2024 | - | -38.86%(-17.5%) |
| Dec 2023 | - | -47.09%(-18.3%) |
| Sep 2023 | - | -57.67%(+51.7%) |
| Jun 2023 | -40.76%(-65.9%) | -38.01%(-39.0%) |
| Mar 2023 | - | -62.34%(-49.5%) |
| Dec 2022 | - | -123.55%(+13.9%) |
| Sep 2022 | - | -108.44%(-8.3%) |
| Jun 2022 | -119.62%(+138.7%) | -118.22%(+18.3%) |
| Mar 2022 | - | -99.92%(+45.5%) |
| Dec 2021 | - | -68.69%(+0.0%) |
| Sep 2021 | - | -68.66%(+36.5%) |
| Jun 2021 | -50.12%(+87.9%) | -50.29%(+25.1%) |
| Mar 2021 | - | -40.21%(+44.7%) |
| Dec 2020 | - | -27.78%(+24.5%) |
| Sep 2020 | - | -22.32%(-32.1%) |
| Jun 2020 | -26.68%(-89.9%) | -32.87%(-66.3%) |
| Mar 2020 | - | -97.50%(-49.6%) |
| Dec 2019 | - | -193.56%(-24.9%) |
| Sep 2019 | - | -257.90%(+26.6%) |
| Jun 2019 | -264.54%(+126.2%) | -203.76%(+144.2%) |
| Mar 2019 | - | -83.43%(-4.7%) |
| Dec 2018 | - | -87.58%(-14.8%) |
| Sep 2018 | - | -102.76%(-20.2%) |
| Jun 2018 | -116.94%(-63.4%) | -128.78%(-49.0%) |
| Mar 2018 | - | -252.28%(-17.9%) |
| Dec 2017 | - | -307.32%(+6.7%) |
| Sep 2017 | - | -288.01%(+3.0%) |
| Jun 2017 | -319.61%(+45.7%) | -279.68%(-3.1%) |
| Mar 2017 | - | -288.59%(+5.5%) |
| Dec 2016 | - | -273.47%(+9.8%) |
| Sep 2016 | - | -249.02%(+27.1%) |
| Jun 2016 | -219.29% | -195.87%(+62.5%) |
| Mar 2016 | - | -120.50%(+12.4%) |
| Dec 2015 | - | -107.25%(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -106.58%(-15.1%) |
| Jun 2015 | -99.20%(+4175.9%) | -125.53%(-95.0%) |
| Mar 2015 | - | -2517.35%(-2400.2%) |
| Feb 2015 | - | 109.44%(+22.4%) |
| Nov 2014 | - | 89.41%(+28.6%) |
| Aug 2014 | -2.32%(-98.9%) | 69.52%(+19.9%) |
| Jun 2014 | -212.18%(-510.6%) | - |
| May 2014 | - | 57.97%(+13.8%) |
| Feb 2014 | - | 50.93%(+3.2%) |
| Nov 2013 | - | 49.33%(-15.4%) |
| Aug 2013 | 51.67%(-39.7%) | 58.29%(-20.8%) |
| May 2013 | - | 73.60%(-12.6%) |
| Feb 2013 | - | 84.22%(-9.9%) |
| Nov 2012 | - | 93.48%(-13.2%) |
| Aug 2012 | 85.65%(-77.7%) | 107.71%(-55.4%) |
| May 2012 | - | 241.36%(-15.6%) |
| Feb 2012 | - | 285.88%(-25.1%) |
| Nov 2011 | - | 381.83%(+15.3%) |
| Aug 2011 | 384.27%(+254.3%) | 331.19%(+93.3%) |
| May 2011 | - | 171.37%(+13.7%) |
| Feb 2011 | - | 150.69%(+35.9%) |
| Nov 2010 | - | 110.87%(-18.8%) |
| Aug 2010 | 108.45%(-111.4%) | 136.50%(-19.9%) |
| May 2010 | - | 170.45%(-18.9%) |
| Feb 2010 | - | 210.10%(-36.4%) |
| Nov 2009 | - | 330.56%(-54.0%) |
| Aug 2009 | -951.82%(+332.6%) | 719.27%(-120.7%) |
| May 2009 | - | -3478.26%(+624.6%) |
| Feb 2009 | - | -480.00%(+129.2%) |
| Nov 2008 | - | -209.38%(+67.3%) |
| Aug 2008 | -220.00%(-15.6%) | -125.16%(-2.8%) |
| May 2008 | - | -128.70%(+1.5%) |
| Feb 2008 | - | -126.86%(-17.2%) |
| Nov 2007 | - | -153.21%(-25.3%) |
| Aug 2007 | -260.64% | -205.02%(+59.4%) |
| May 2007 | - | -128.62% |
FAQ
- What is Aytu BioPharma annual return on equity?
- What is the all time high annual ROE for Aytu BioPharma?
- What is Aytu BioPharma annual ROE year-on-year change?
- What is Aytu BioPharma quarterly return on equity?
- What is the all time high quarterly ROE for Aytu BioPharma?
- What is Aytu BioPharma quarterly ROE year-on-year change?
What is Aytu BioPharma annual return on equity?
The current annual ROE of AYTU is -47.24%
What is the all time high annual ROE for Aytu BioPharma?
Aytu BioPharma all-time high annual return on equity is 384.27%
What is Aytu BioPharma annual ROE year-on-year change?
Over the past year, AYTU annual return on equity has changed by -6.48% (-15.90%)
What is Aytu BioPharma quarterly return on equity?
The current quarterly ROE of AYTU is -20.38%
What is the all time high quarterly ROE for Aytu BioPharma?
Aytu BioPharma all-time high quarterly return on equity is 719.27%
What is Aytu BioPharma quarterly ROE year-on-year change?
Over the past year, AYTU quarterly return on equity has changed by +37.29% (+64.66%)